Finance

Pharmaceutical company files for initial public offering

Published in Drug Week, April 2nd, 2004

Alnylam Pharmaceuticals, Inc., announced that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to an initial public offering of its common stock.

All the shares of common stock to be offered by the company will be newly issued shares.

Banc of America Securities LLC is acting as the sole book-runner and lead manager, and Citigroup Global Markets, Inc., Piper Jaffray & Co. and ThinkEquity Partners LLC are acting as co-managers.

The number of shares to be offered and the price range for the offering have not yet been determined. The offering will be made only by means of a prospectus, a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2004-04-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry